DOC
SLIDES
Featured
Recent
Articles
Topics
Upload
Login
Sign Up
Featured
Recent
Articles
Topics
Upload
Login
Sign Up
Home
›
Search Results for "arv hiv"
Search Results for 'arv hiv'
arv hiv published presentations and documents on DocSlides.
Global Price Reporting Mechanism (GPRM); ARV Drug Regulatory Status Database (DRS); ARV Active Ph
by luanne-stotts
relevance and options for the future. B. Dongmo N...
ARV Procurement and Value For Money
by marina-yarberry
Cameroon Perspectives . IAS, Paris 23 July, . 201...
Eliminating Perinatal HIV Transmission
by jane-oiler
A Curriculum for OB/GYN Resident and Midwifery Pr...
Newborn born TO hiv ( )
by test
mother. ID weekly conferences. Gouri Scheurmann ....
HIV/AIDS DEPARTMENT 2013 Consolidated ARV Guidelines
by stefany-barnette
Treatment Recommendations for Pregnant and Breast...
“Getting to Zero: Thailand’s
by aaron
Experience with E-MTCT”. Petchsri. . Sirinirun...
Presenters Kathryn Burnett, PharmD, BCPS, BCIDP
by jade
Madeline Droney, PharmD. In it for the Long-Haul. ...
Clinical aspects of ADRs in HIV and ARV toxicity monitoring approaches
by myesha-ticknor
Clinical aspects of ADRs in HIV and ARV toxicity ...
New Directions in the 2015 Consolidated ARV Guidelines Update
by test
Meg . Doherty, MD, PhD, MPH. 19 July 2015. WHO Sa...
Ulwazi malunga nokungasebenzi
by marina-yarberry
(. kwamayeza. ) e HIV. Kukuthini. . ukungeva. ?...
Assoc.Prof
by yoshiko-marsland
. . Thanyawee. . Puthanakit. , MD.. Division of ...
Scaling up what works: replicating models on community serv
by yoshiko-marsland
Jennifer Gatsi Mallet. Namibia Women’s Health N...
FINANCING ARV
by tatiana-dople
EXPERIENCE FROM MALAYSIA. BY. SHA’ARI NGADIMAN,...
High-dose rifampicin
by pasty-toler
TB treatment regimen to . reduce . 12-month . mor...
Promoting Adherence and Retention in ARV-based Prevention
by briana-ranney
Dr. Seema Sahay, Ph.D. Division of Social and Beh...
Diagnosis and Initial Management of HIV/AIDS:
by cheryl-pisano
What the Primary Care Provider Should Know. Carol...
Cancer in HIV Patients in Latin America and the Caribbean:
by SugarLips
Characteristics in seven sites from the . CCASAnet...
CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure
by brown
Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...
The ART of HIV Management:
by briana-ranney
An Antiretroviral Therapy Review. Sarah Pérez, P...
Potential safety issue affecting women living with HIV using
by luanne-stotts
dolutegravir. at the time of conception. Meg Doh...
Perinatal HIV Transmission Prevention
by sherrill-nordquist
Missed Opportunities. Ryan White 2012 Conference....
Dr Vincent Habiyambere & Boniface Dongmo Nguimfack
by myesha-ticknor
Strategic Information and Planning (SIP) – WHO ...
Subgroup Efficacy Analyses of
by eddey
Long-Acting Subcutaneous Lenacapavir in . Heavily ...
New Science, New Hope: Giving Women Power Over
by joyce
AIDS. The John Kevany Memorial Lecture. Zeda Rosen...
29% abnormal scores in
by Thrillseeker
screening for . depression and anxiety. All 26 ado...
New drugs for individuals
by Ziggystardust
with multi-resistant virus. 6 APRIL 2020. Faculty....
CNS pharmacology of antiretroviral
by PlayfulSpirit
drugs. . and. relevant . interactions. . betwee...
Cases From the Clinic( ians
by ImNotABaby
):. Antiretroviral Therapy Cases . and . Panel Dis...
ARV Resistance 1 Learning Objectives
by naomi
Define drug resistance. Identify . factors that in...
Kebijakan Program Pencegahan
by blondiental
dan . Pengendalian . HIV . AIDS . dan. . PIMS. K...
New Directions in the future 2015
by mitsue-stanley
Consolidated ARV Guidelines Update. Meg . Doherty...
Non-ARV Based Interventions to Combat
by tatiana-dople
Non-ARV Based Interventions to Combat HIV/AIDS:...
The Kabeho Study*: Kigali
by phoebe-click
Antiretroviral and Breastfeeding Assessment for t...
Innovative Strategies for the Management
by karlyn-bohler
of HIV Infection. Dual therapies without NRTIs. J...
The challenge of maintaining care and support to HIV infect
by natalia-silvester
Dr Doumbouya Bangaly. 1. Background. . Post elec...
New Prevention Technologies Workshop
by karlyn-bohler
Module 1: . Basic definitions. www.icad-cisd.com....
CDC’s Interim Guidance on the Use of PrEP in Heterosexual
by calandra-battersby
Adults:. . Implications . for Clinical Practice....
Track B
by karlyn-bohler
Clinical Science, Treatment and Care. ZIMBABWE ...
Quantitative Adherence Measurement In Infants Receiving ARV Syrups:
by ellena-manuel
P1115 . Zimbabwe. , Harare Family . Care Experien...
Comprehensive Guideline Summary
by aaron
Guidelines for the Use of Antiretroviral Agents. ...
Load More...